Views & Analysis | Perspectives on pharma industry issues

Digital

pharmaphorum podcast Episode 284, Mati Gill, AION Labs

AI, start-ups, and the future of human health: AION Labs’ Ma...

In a new episode of the pharmaphorum podcast, Nicole Raleigh invites Mati Gill, CEO of AION Labs, back as guest.

R&D

Auto vacuum sealed vaccines in manufacturing plant

Reliability in life sciences logistics: What good looks like

What constitutes a reliable supply chain is changing rapidly.

Oncology

How AI is advancing patient subgroup identification in oncol...

With the advent of AI, it’s now possible to enrich clinical trials for patient subgroups more precisely than ever before.

Oncology

Personal reflections on World ADC, San Diego

At World ADC this month, the latest advances in ADC discovery and development were presented, debated, and reflected upon.

Oncology

ESMO26: Taiho Oncology on improving the lives of patients wi...

Dr Harold Keer, chief medical officer at Taiho Oncology, discusses the Phase 2 REZILIENT2 trial data presented at ESMO26 and the NSCLC setting.

Articles

Personalised healthcare and the patient

We interview Dr Bob Holland of AstraZeneca on recent advances in personalised medicine, how these will impact on the patient and AstraZeneca’s personalised healthcare strategy. As personalised medicine slowly becomes a reality it is easy to focus on the therapeutic advances and forget about the impact...

Articles

Interview with Kevin Hrusovsky part 1: molecular interaction...

In the first of this three-part interview series, Kevin Hrusovsky shares the most exciting recent advances in understanding molecular interactions of a disease. Recently we have seen some very exciting breakthrough in our understanding of molecular interactions of diseases, notably in breast cancer...

Articles

Personalized medicine – what does the future hold?

Dr. John Hornberger explains why it is such a pivotal time right now for personalized medicine and how the future direction of this area is being decided right now! Personalized medicine is at a crucial standpoint right now and the future landscape is being dictated by current decisions in...

Sales & Marketing

Benefits of marketing with AI tools, upward trajectory graph

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Sales & Marketing

Building a social presence inside regulatory guardrails

In the UK, promoting prescription-only medicines to the public is prohibited by law and by the ABPI Code - social media reactions and shares included.

Digital

AI, start-ups, and the future of human health: AION Labs’ Ma...

In a new episode of the pharmaphorum podcast, Nicole Raleigh invites Mati Gill, CEO of AION Labs, back as guest.

Digital

A sponsored video interview with Axria's Jeff Kaminski

Why AI transformation is really about people

Jeff Kaminski, global head of AI and data at Axtria and a former industry analyst, discusses culture, governance, and leadership challenges around AI.